Cargando…
Leveraging Genomic and Bioinformatic Analysis to Enhance Drug Repositioning for Dermatomyositis
Dermatomyositis (DM) is an autoimmune disease that is classified as a type of idiopathic inflammatory myopathy, which affects human skin and muscles. The most common clinical symptoms of DM are muscle weakness, rash, and scaly skin. There is currently no cure for DM. Genetic factors are known to pla...
Autores principales: | Irham, Lalu Muhammad, Adikusuma, Wirawan, La’ah, Anita Silas, Chong, Rockie, Septama, Abdi Wira, Angelina, Marissa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451728/ https://www.ncbi.nlm.nih.gov/pubmed/37627776 http://dx.doi.org/10.3390/bioengineering10080890 |
Ejemplares similares
-
Transcriptomics-driven drug repositioning for the treatment of diabetic foot ulcer
por: Adikusuma, Wirawan, et al.
Publicado: (2023) -
A bioinformatic approach to identify pathogenic variants for Stevens-Johnson syndrome
por: Ma’ruf, Muhammad, et al.
Publicado: (2023) -
Identification of druggable genes for multiple myeloma based on genomic information
por: Satria, Rahmat Dani, et al.
Publicado: (2023) -
Genomic variants-driven drug repurposing for tuberculosis by utilizing the established bioinformatic-based approach
por: Irham, Lalu Muhammad, et al.
Publicado: (2022) -
Integration of genomic variants and bioinformatic-based approach to drive drug repurposing for multiple sclerosis
por: Afief, Arief Rahman, et al.
Publicado: (2022)